Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2021 · 10-Q
Revenue$4.03M$4.03M+29.3% vs Q1 2020 Net Income-$2.54M-$2.54MN/M vs Q1 2020 EPS Diluted-$0.13-$0.13N/M vs Q1 2020 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flow-$2,131,000N/M Free Cash Flowderived-$2,171,000— Margins · derivedGross margin64.9%
Operating margin-54.1%−15.3 pt vs Q1 2020
Net margin-63.0%+3.0 pt vs Q1 2020
ended Mar 31, 2021 · filed May 11, 2021 · 41 d after period end